Evidence map›Paper›PMID 33792283›Full record

ArticleACS biomaterials science & engineering2021

In Vivo Evaluation of the Regenerative Capability of Glycylglycine Ethyl Ester-Substituted Polyphosphazene and Poly(lactic-

Kenneth S Ogueri, Kennedy S Ogueri, Aneesah McClinton, Ho-Man Kan, Chinedu C Ude, Mohammed A Barajaa, Harry R Allcock, Cato T Laurencin

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS biomaterials science & engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Development of porcine skeletal muscle extracellular matrix-derived hydrogels with improved properties and low immunogenicity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Polyphosphazene-Based Biomaterials for Biomedical Applications.International journal of molecular sciences · 2022
    Review
  6. Cyclo- and Polyphosphazenes for Biomedical Applications.Molecules (Basel, Switzerland) · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kenneth S OgueriDepartment of Materials Science and Engineering, University of Connecticut, Storrs, Connecticut 06269, United States.ORCID 0000-0002-9529-6259
Kennedy S OgueriDepartment of Chemistry, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.ORCID 0000-0002-3847-8988
Aneesah McClintonConnecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health Center, Farmington, Connecticut 06030, United States.
Ho-Man KanConnecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health Center, Farmington, Connecticut 06030, United States.
Chinedu C UdeConnecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health Center, Farmington, Connecticut 06030, United States.
Mohammed A BarajaaConnecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health Center, Farmington, Connecticut 06030, United States.
Harry R AllcockDepartment of Chemistry, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.ORCID 0000-0002-8822-3457
Cato T LaurencinDepartment of Materials Science and Engineering, University of Connecticut, Storrs, Connecticut 06269, United States.ORCID 0000-0001-6765-3047
Pennsylvania State University · USUConn Health · USUniversity of Connecticut · US

Funding

Regenerative Engineering of Complex Musculoskeletal Tissues and JointsDP1AR068147 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LAURENCIN, CATO T. · 2014 to 2018
$4.1M
NIAMS NIH HHS DP1 AR068147
6 · The paper itself

Abstract

In an effort to understand the biological capability of polyphosphazene-based polymers, three-dimensional biomimetic bone scaffolds were fabricated using the blends of poly[(glycine ethylglycinato)

Indexed as

GlycylglycinePolyglycolic AcidAnimalsBone and BonesEstersGlycolsLactic AcidOrganophosphorus CompoundsPolylactic Acid-Polyglycolic Acid CopolymerPolymersRabbitsTissue ScaffoldsX-Ray MicrotomographyEstersGlycolsGlycylglycineLactic AcidOrganophosphorus CompoundsPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolymerspoly(phosphazene)biocompatible polymersbiodegradable polymerscritical-sized bone defectpoly(lactic-co-glycolic acid)polyphosphazenesregenerative biomaterials

Identifiers

PMID33792283
PMCPMC8084594
OpenAlexW3148192518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.